Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Windtree Therapeutics: Discussion of Licensing Deal with Lees Pharmaceutical and Two Imminent Key Clinical Events (WINT, Buy, $0.90)


This report discusses a new licensing deal with Lees Pharmaceutical and alerts investors to two upcoming catalysts for the stock.…
Read more…